|
    |
COMMERCIAL WORKSHOP INFORMATIONS
Date, time, and location
Thursday, 5 June
8.30
– 10.00 : sponsored workshops 1 and 2 by Thermo (room
Lafitte) and Roche (room Sapotille)
10.30 – 12.00 : sponsored workshops 3 and 4 by Waters (room
Lafitte) and Inverness Medical innovations (room Sapotille)
14.00 – 15.30 : sponsored workshops 5 and 6 by Applied
Biosystems (room
Lafitte) and Randox (room Sapotille)
Friday,
6 June
17.00 18.30 : sponsored workshops 7 and 8 by Agilent (room
Lafitte) and Siemens (room Sapotille)
PROGRAM

Thermo Fischer
Increasing
the Productivity of GC-MS and LC-MS Toxicology and Forensic Analysis,
Workshop Description: Moving Toxicology and Forensic Science Forward -
the effective use of Thermo Scientific products and expertise.
Talk 1: Utilizing TurboFlow On-Line Sample
Preparation and FAIMS for Improved Identification and Quantitation
of Drugs of Abuse by LC-MS/MS (Sarah Robinson, Clinical Marketing
Specialist, Thermo Fisher Scientific)
Talk 2: LCMS Toxicology Screening with ToxID Software
(Taha Rezai, Clinical and Toxicology Marketing Specialist, Thermo
Fisher Scientific)
Talk 3: Solutions for Routine GC/MS Toxicology
Analysis Based on Workflow Oriented Software (Jason Cole, Toxicology
Market Manager, Thermo Fisher Scientific)
Talk 4: Special Guest Speaker

Roche Diagnostics
Title - "The Value of Oral
Fluid Drug Testing"
Description - Oral fluid provides a quick, non-invasive specimen
for testing. The objective of this session is to provide an overview
of the utility of oral fluid testing from a clinical and laboratory
perspective.
Topics covered include the history, application and advantages of
oral fluid as a matrix, and the clinical utilities of oral fluid
drug testing.
This workshop is co-sponsored by Roche Diagnostics and OraSure
Technologies Inc and the speakers will likely be company
representatives.
Waters
Attend our workshop entitled "Recent
Advances in Liquid Chromatography and Mass Spectrometry for Forensic
Toxicology". Waters has been working with leading toxicology
laboratories to develop applications to meet the challenges of
screening and targeted analysis in the forensic laboratory.
This workshop will bring together forensic toxicologists to share their
recent experiences in the analysis of drugs of abuse and
improvements these technologies enable in sample throughput, complex
sample analysis and sample preparation.
Please join us to learn more about the implementation of Waters LC/MS
solutions along with the scientific and business advantages these
solutions deliver.

Inverness Medical Innovations
Inverness Medical Innovations (IMI)
is a world leader in the field of diagnostic products to assist
laboratory and healthcare professionals in both preventative and
interventional medicine.
With drug abuse continuing to be a global healthcare problem, IMI
are responding to the demand for improved drugs of abuse testing in
healthcare settings, social work, rehabilitation and the workplace
by offering one of the most comprehensive lines of drugs of abuse
tests available today.
Thursday 5th June 10.30am Sapotille Room
Chairman: Professor
Wennig
Talk One – Prof. Verstraete :
Substitution treatment for opiate addiction: the good, the bad and
the ugly.
Talk Two – Prof. Wennig : The
growing health issue of Cocaine
Talk Three - Andrew Leibie :
Australasian workplace drug testing: Challenge and efficiency of
point of care (POC) testing

Applied Biosystems
"Advances in the use of LC/MS/MS for Forensic
Toxicology Analysis"
The
following workshop will provide an introduction to the technique of
LC/MS/MS and go on to discuss the use of this technology for the
screening and quantification of drugs of abuse and well as the
practical considerations when implementing such technology for
routine forensic testing.
Talk
1:
Dr. Tania Sasaki, Clinical Research and Forensics Technical
Marketing Specialist, Applied Biosystems
Introduction to LC/MS/MS and its use screening and quantitative
analysis
Talk
2:
Dr. Wolfgang Weinmann, Professor, University of Freiburg, Department
of Legal Medicine
The
Implementation and Use of LC/MS/MS for Routine Drug Screening and
Quantitation

Randox Laboratories
Évaluation du dépistage de quatre classes de stupéfiants et des
benzodiazépines dans le sang total laqué par l'analyseur Evidence
Investigator
Abstract - Evaluation of screening for drugs of abuse and
benzodiazepines in forensic blood samples using Evidence
InvestigatorTM analyser. Introduction: Semi-quantitative detection
of 4 classes of drugs of abuse (opiates, cocaine, cannabinoids and
amphetamines) and benzodiazepines in haemolysed whole blood by
Evidence Investigatorr analyser has been evaluated in this study.
128 forensic blood samples known to be positive for at least one of
these classes by chromatography coupled to mass spectrometric
detection were analysed. Results and discussion: Specificity was
79.0 % for amphetamines, 98.1 % for cannabinoids, and 100 % for
opiates, cocaine, and benzodiazepines.
Sensitivity was 33.3 % for amphetamines, 78.4 % for benzodiazepines,
93.2 % for cannabinoids, 93.5 % for opiates and 95.2 % for cocaine.
3.9 % of false negatives were observed all classes taken together,
due to low concentrations of analytes or due to a bad recognition of
some analytes by antibodies. The 4.0 % of false positive results
were predominantly observed during amphetamines detection, probably
due to presence of biogen amines, as it has previously been
reported. An improvement of the technique has been carried out by
adding a supplementary wash step during sample preparation. An
optimisation of cuto. levels is possible to reduce false negative
results during benzodiazepines and cannabinoids detection.
Conclusion: This immunoanalytical method enables an efficient
detection of opiates, cocaine, cannabinoids and benzodiazepines in
forensic blood samples. However a further confirmation and
quantification by mass spectrometry techniques remains necessary.

Agilent Technologies
Speaker Agilent : Michelle Moore
17.15
Welcome with cocktails and food
17.30 Keynote speaker: “Poisons of the
Caribbean” (Michelle Moore)
18.00 Q & A
18.15 informal poster session with Agilent technical specialists
Open end
Participants are welcome to join anytime for interesting talks,
lecture, food and drinks

Siemens
"Antibodies: From Structures to Immunoassays"
The speaker will be Dr. William Bedzyk, Principal Scientist, Siemens
Healthcare. The workshop will offer a discussion on the function and structure of antibodies, the various types, specific considerations
when producing antibodies to elicit the correct response, and the
actual process used to make antibodies followed by examples
|
<